Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tislelizumab Antineoplastic Agents, Immunological”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)UnknownNCT04981665
What this trial is testing

Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Who this might be right for
Hepatocellular CarcinomaAdjuvant Therapy
Zhejiang University 50
Testing effectiveness (Phase 2)UnknownNCT04922047
What this trial is testing

Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)

Who this might be right for
Urinary Bladder NeoplasmsUrologic NeoplasmsUrogenital Neoplasms+3 more
RenJi Hospital 6
Testing effectiveness (Phase 2)UnknownNCT06134193
What this trial is testing

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Who this might be right for
CarcinomaIntrahepatic CholangiocarcinomaGallbladder Cancer+5 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 41